MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system.

Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.